Efficacy and Safety of 20 mg Sumatriptan Powder Delivered Intranasally With the Bi-directional Device Compared With 100 mg Sumatriptan Tablets in Adults With Acute Migraine With or Without Aura

Clinical trial NCT01667679 · COMPLETED

Trial details

NCT number: NCT01667679
Sponsor: Avanir Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Migraine Headaches

Start date: 2012-08-01
Primary completion: 2014-03-01
Enrollment: 275

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.